Last reviewed · How we verify

NCT06746649: CAEx

Time-specific Exercise in Circadian Context

Active, enrolled NA Last updated 24 December 2024
What this trial tests

NA trial testing Combined training in Osteopenia in 34 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
1 February 2024
Primary endpoint
4 July 2024
30 March 2025

Quick facts

Lead sponsorComenius University
PhaseNA
StatusActive, enrolled
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposeprevention
Enrollment34
Start date1 February 2024
Primary completion4 July 2024
Estimated completion30 March 2025
Sites1 location across Slovakia

Drugs / interventions tested

Conditions studied

Sponsor

Comenius University

Who can join

Adults 65 to 80, any sex, with Osteopenia or Osteoporosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The project aims to explore the mechanisms, by which physical activity can support healthy ageing and decrease the negative impact of ageing on the circadian system, musculoskeletal system and immunity.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Combined training

Trials testing the same drug.

Other recruiting trials for Osteopenia

Currently open trials in the same condition.

Other Comenius University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06746649.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing